Related Experiment Video

Updated: Jun 19, 2026

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

Arrest defective-1 controls tumor cell behavior by acetylating myosin light chain kinase

Dong Hoon Shin1, Yang-Sook Chun, Kyoung-Hwa Lee

  • 1Department of Pharmacology, Ischemic/Hypoxic Disease Institute, Seoul National University College of Medicine, Chongno-gu, Seoul, Korea.

Plos One
|October 15, 2009
PubMed
Abstract

Insights

Human arrest defective-1 (hARD1) deactivates myosin light chain kinase (MLCK), inhibiting tumor cell migration and invasion. This discovery positions hARD1 as a potential therapeutic target for preventing cancer metastasis.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cellular Motility

Background:

  • Cell motility is crucial for tumor cell spreading.
  • Myosin light chain kinase (MLCK) regulates cell behavior and is a target for preventing cancer metastasis.
  • Human arrest defective-1 (hARD1) was identified as a potential MLCK-interacting protein.

Purpose of the Study:

  • To investigate if hARD1 regulates MLCK activity.
  • To determine hARD1's role in controlling tumor cell motility.
  • To explore hARD1 as a therapeutic target for cancer invasion and metastasis.

Main Methods:

  • Yeast two-hybrid screening to identify interactions.
  • In vivo and in vitro immunoprecipitation assays.
  • Affinity chromatography and mutation studies to confirm acetylation and binding sites.

Main Results:

  • hARD1 physically interacts with MLCK.
  • hARD1 acetylates and deactivates Ca(2+)-activated MLCK, reducing MLC phosphorylation.
  • hARD1 inhibits tumor cell migration and invasion in an MLCK-dependent manner.
  • Acetylation of Lys608 in MLCK's IgG motif by hARD1 is crucial for inactivation.

Conclusions:

  • hARD1 is a genuine regulator of MLCK.
  • hARD1 is vital for balancing tumor cell migration and stasis.
  • hARD1 represents a promising therapeutic target to prevent tumor invasion and metastasis.

More Related Videos

Optogenetic Inhibition of Rho1-Mediated Actomyosin Contractility Coupled with Measurement of Epithelial Tension in Drosophila Embryos12:35

Optogenetic Inhibition of Rho1-Mediated Actomyosin Contractility Coupled with Measurement of Epithelial Tension in Drosophila Embryos

Published on: April 14, 2023

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter11:32

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter

Published on: March 27, 2020

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...